Dolutegravir Impact on Residual Replication
Clinical trial NCT02500446 · COMPLETED
Trial details
- NCT number
- NCT02500446
- Sponsor
- University of Melbourne
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-28
- Primary completion
- 2016-09-16
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.